Seed · Biotech · Liège, Belgium · Founded 2023 · 2–10 employees
Quidditas Therapeutics is a Liège-based biotech startup developing a next-generation genome editing platform (GREAT) that enables precise, large-scale genetic recombination for applications in gene therapy, protein bioproduction and regenerative medicine; it raised €2.62M in May 2025 led by iXLife Capital with support from Key Ventures and a Walloon government grant to accelerate R&D and address rare and complex diseases.
No open roles listed right now.